ABSTRACT Background: Globally, over 170 million people have diagnosed DM, and by the year 2030, the prevalence is estimated to raise 2.5-fold. Diabetes mellitus (DM) is one of the strongest predictors of peripheral arterial occlusive disease and a significant risk factor for progression of asymptomatic disease or claudication into critical limb ischaemia (CLI). Critical limb ischaemia is the most advanced stage of peripheral arterial occlusive disease. The prognosis is poor, with amputation rates up to been 30% and mortality up to 25 % after 1 year.
INTRODUCTION
Globally, over 170 million people have diagnosed DM, and by the year 2030, the prevalence is estimated to raise 2.5-fold
(1).
Diabetes mellitus (DM) is one of the strongest predictors of peripheral arterial occlusive disease and a significant risk factor for progression of asymptomatic disease or claudication into critical limb ischaemia (CLI) (2) . Critical limb ischaemia is the most advanced stage of peripheral arterial occlusive disease. The prognosis is poor, with amputation rates up to been 30 % and mortality up to 25 % after 1 year
(3)
. Diabetic patients who develop CLI are more prone to ischaemic events with an impaired functional status. Approximately 80 % of diabetes related lower limb amputations are preceded by a diabetic foot ulcer (4) . Treatment of CLI aims at wound healing, improvement in quality of life, limb loss prevention, and prolonged survival. Current strategies propose open or endovascular revascularization of tibial arteries with runoff through the ankle, but not specifically targeted to the location of ischaemia (5) . To achieve healing of an ischaemic foot ulcer and save the leg from amputation, revascularization, endovascular or open surgery, with sufficient wound perfusion is necessary. In recent years, selection of the artery for revascularization has been the subject of discussion, the angiosome concept has been introduced (6) .
AIM OF THE WORK
The aim of this work is to evaluate the role of endovascular treatment of tibial artery occlusive disease in diabetic patients, as regard to efficacy, safety, as well as complications. 
PATIENTS AND METHODS

Statistical Methods
All the collected data were coded on the computer and the statistical analysis was done using SPSS program (Statistical Package for Social Science). Procedure success was defined as: PTA resulting in less than 50% residual stenosis of the original lesion after dilatation. The pre-intervention mean ABPI for the entire cohort (excluding patients with sever calcfications) was 0.290.2, which improved to 0.580.17 immediately post-intervention (P<0.001). When evaluated after 1 months postprocedure, it improved to 0.620.19 (P<0.001), after 3 months to 0.700.20, after 6 months to0.750.20. (P< 0.001). 
RESULTS
After one month 14 70 After 3 months 14 70 After 6 Months 12 60 Patency at follow-up was documented by means of colour duplex ultrasound: < 50% diameter reduction (peak systolic velocity index < 2.4), 50% or more diameter reduction (peak systolic velocity index > 2.4) and complete occlusion. Primary patency at 1 and 3 months was defined as Freedom from restenosis (Ultrasound patency); restenosis was defined by a peak systolic velocity index > 2.4 at the target lesion.
DISCUSSION
Diabetic patients are more likely to develop CLI and its serious complications including gangrene, and to have higher morbidity and mortality.
Also, diabetes mellitus is one of the possible determinant factors of graft failure in patients with CLI. For these reasons, Tibial angioplasty is currently proposed as the primary treatment for CLI in diabetic patients. Tibial angioplasty, however, has been criticized because of the small diameter and length of the treated vessel, both of which have a tendency towards a high restenosis rate; furthermore, it is not clear whether the clinical success of Tibial angioplasty is due solely to technical success (7) . A recent meta-analysis of Tibial angioplasty for CLI reports that the durability of PTA is limited compared with bypass surgery. Nevertheless, for this kind of patients, the main result is not to avoid restenosis and maintain distal pulse, but to restore a straight line blood flow (sometimes as a "temporary bypass") for the time that is necessary to provide wound healing and limb salvage, favouring the treatment of infections where needed . According to TASC II, there is growing evidence supporting this treatment for limb salvage in patients who have stenotic or occluded tibial arteries, but only when there is presence of distal run-off in the foot in patients at high surgical risk. There is 90% success rate in immediate outcomes of the endovascular treatment of distal lesions
(7)
.
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Studies have shown that the most important aspect of life quality for CLI in diabetic patients is actually that of limb salvage. Compared to other markers such as rest pain and ulcer healing, it is believed that limb salvage should be the goal in most patients with CLI. Hence, leaving the patient with an ambulatory foot should be the paramount goal (9) . Long-term patency is not as relevant in this patients, because less blood flow is generally required to maintain tissue integrity than to achieve wound healing. Therefore, temporary 6 months restoration of straight-line flow to the foot may be sufficient to relieve CLI, while collateral flow may be all that is necessary to preserve tissue integrity. Because of this, the long-time patency in the treated segments wasn't the primary objective of this study.
This study was concentrating on the outstanding role of Tibial angioplasty for the management of critical lower limb ischemia in diabetic patients
The present study demonstrates technical success as well as safety, efficacy and practicability and estimates the early results as limb salvage and patency rates of Tibial balloon angioplasty for diabetic patients with critical lower limb ischaemia.
In this study, patients age ranged between 50 years and 87 years with a mean age 66.7  12.35.
The higher mean age and the greater prevalence of diabetic, renal, cardiac, and hypertensive identify a very fragile population at high surgical risk, for which endovascular treatment represents the hope to avoid amputation, and improve functional status and quality of life.
Analysis of the effects of various demographic factors like; age, sex, D.M., smoking, hypertension, dyslipidaemia, associated diseases (cardiac, renal, CVD), the presence of more than one risk factor had revealed that: age > 70 years had poor outcomes due to the severity of the atherosclerotic disease affecting the patients; Also the association of more than one risk factor has a highly significant poor prognosis.
In this study, the pre-intervention mean ABPI for the entire cohort excluding patients with sever calcfications was 0.290.2, which improved to 0.260.17 one month post-intervention (P<0.001). When evaluated after 3 months postprocedure, it improved to 0.700.19 (P<0.001) and after 6 months to 0.750.20.
In 3 diabetic patients (15%) there was severe medial calcifications affecting the tibial vessels and the ABPI was falsely elevated (>1.2), so that evaluation of those patients with ABPI was not statistically significant.
Technical success was defined as: PTA resulting in less than 50% residual stenosis of the original lesion after dilatation.
In this study, the primary technical success rate was achieved in 13 patient (80%). 9 of them (45%) had optimal technical success, 4 patients (20%) had suboptimal technical success and 7 patients (35%) had technical failure.
In this study, Clinical success was defined as relief of rest pain or healing of the ulcer and limb salvage, based on Rutherford categories. Of 4 patients (15%) suffering from rest pain, 3 patients (75%) become asymptomatic and 1 patient (25%) underwent BK amputation. Of 17 patients (85%) suffering for minor tissue loss, improve Healing was achieved in 9 patients (69.2%) and 4 patients (30.8%) underwent major amputations.
Undoubtedly, clinical success has little correlation with patency of the treated vessel. The term patency derives from surgical revascularization literature and is used to describe the presence of uninterrupted flow. By definition, the term reflects the findings of objective imaging such as duplex ultrasound, digital subtraction angiography, computed tomographic or magnetic resonance angiography (10) . In this study, the primary patency rate was (70%) at 1 and 3 months and (60%) at 6 months This result reflects a decline of patency rate by time, however the long-term complete patency of the treated vessels less important in such patients than in those with coronary, carotid or renal arterial disease: the re-canalization temporarily increases blood flow to the foot and has a positive effect in eradicating infection and healing ulcers and surgical wounds, thus the rate of major amputations in this study still low after 12 months of angioplasty.
There are differences in primary patency between studies in literature that may be due to the heterogeneity of the patient groups rather than to the differences in angioplasty technique.
Earlier reports have even greater variability in outcomes with less objective measurement criteria to assess re-stenosis or occlusion. In 2001, Lofberg et al. (8) reported 86 infrapopliteal interventions for CLI, defining clinical success as symptomatic improvement and an increase in ABI of > 0.1. Rates for 1-, 2-, and 3-year clinical success were 51%, 36%, and 36%, respectively, and 3-year limb salvage was 72%.
In this study, Patency at follow-up was documented by means of colour duplex sonography: <50% diameter reduction (peak systolic velocity index < 2.4), 50% or more diameter reduction (peak systolic velocity index > 2.4) and complete occlusion. Primary patency at 1 and 3 months was defined as Freedom from restenosis (Ultrasound patency); restenosis was defined by a peak systolic velocity index > 2.4 at the target lesion.
CONCLUSION
On the basis of the obtained results, it can be concluded that:  Tibial angioplasty demonstrated its feasibility, safety and effectiveness in the treatment of diabetic patients with CLI.  Limb salvage should be the main goal in patients with CLI due to infrapopliteal occlusive disease. With a prompt diagnosis, treatment can be started early and serious consequences may be avoided. Revascularisation that can prevent amputation is the ultimate treatment strategy.  Tibial angioplasty is a low-risk and minimally invasive procedure, which rarely compromises a later surgical procedure, and at the same time preserves the saphenous vein for future coronary or lower extremity distal bypass surgery.  Tibial angioplasty showed favorable clinical outcomes in terms of technical success, primary patency, high rate of limb salvage and amputation-free survival.  It carries a lower morbidity and mortality and shorter hospital stay compared with surgery but with high cost.  All the above reasons are encouraging and support the endovascular revascularization as the first treatment option in all patients with CLI who would otherwise be offered distal bypass surgery or amputation, as failure rarely precludes surgery.  Correct pre-procedural investigation and planning, appropriate revascularization techniques and adequate post-procedural follow-up and medical management are crucial to the desired clinical outcome.
 Although it is still a technically challenging procedure, more aggressive treatment with advanced devices and more clinical experience would allow the interventionist to treat increasingly complex and diffuse patterns of disease.
